These effects of estradiol involved the nuclear estrogen receptor α (ERα), and distribution of ERα in malignant ovarian tumor tissue overlapped with a marker for cell proliferation as well as with lower apoptotic activity [3]. This evidence concerns the gene ESR1 and ovarian neoplasm.